The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss.

Saved in:
Bibliographic Details
Title: The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss.
Authors: Zheng T; College of Pharmacy, Sookmyung Women's University, Yongsan-ku, Seoul, Republic of Korea., Kang JH; College of Pharmacy, Sookmyung Women's University, Yongsan-ku, Seoul, Republic of Korea., Sim JS; College of Pharmacy, Sookmyung Women's University, Yongsan-ku, Seoul, Republic of Korea., Kim JW; Department of Pharmacology and Dental Therapeutics, Research Center for Biomineralization Disorders, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea., Koh JT; Department of Pharmacology and Dental Therapeutics, Research Center for Biomineralization Disorders, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea., Shin CS; Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Republic of Korea., Lim H; Departments of Physics, Hunter College of the City University of New York, New York City, New York, USA., Yim M; College of Pharmacy, Sookmyung Women's University, Yongsan-ku, Seoul, Republic of Korea.
Source: Oncotarget [Oncotarget] 2017 Aug 28; Vol. 8 (44), pp. 76558-76573. Date of Electronic Publication: 2017 Aug 28 (Print Publication: 2017).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.20576